for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

Mines said that while the material first started being used to make plastic bags, the market for bioplastics has now broadened. He added that the company is now starting to get enquiries and orders from massive brand owners.

http://www.prw.com/homePBP_NADetail_UP.aspx?ID_Site=818&ID_Article=25180&mode=1&curpage=0

Monosol deal already contributing profit.{Deal was signed in June}?

http://packagingnews.co.uk/business/news/842573/Stanelco-moves-towards-profit/

The results suggest SEO is operating at the same loss as last year. (3.something minus 2 million exceptionals equals about 1.6)
I can't get excited about nothing.
Filed away for another six months.
See you in the new year................ unless

Hi all - Not looked here since June. Only 100 posts. I have some shares that get that in an afternoon!

I went to Marchwood today as part of a group of 8 shareholders.
I do feel (as Sharesure said above) they have got it together at last. Here is my first reaction which I posted on SirMs thread on AFUN-

-- - - - - - - - - - - -
8 of us had a very good presentation by Paul Mines (CEO), backed up with tour of both the RF and BioPlast R&D workshops (if that is the term).
Present throughout and contributing regularly were Clive Warner (FD), Paul Law (MD BioPlastics), David Battey (Business Developoment Director), Donna Siimpson (Solicitor and Commercial Executive) with Caroline Stewart from Financial Dynamics.

The presentation slides are available on SEO Website.

Nothing new, nothing earth shattering, but the overriding story is of a Company with its act together and working as a term. A very knowledgeable and enthusiastic team. A team that knows what it is doing and where it is going and seemingly getting there.

They would not be drawn on anything not yet in the public domain.

I consider it a day well spent. I am increasingly happy to keep my holding here. It is just a pity it is now not worth anywhere near as much as when I put it in - but that will come, I feel increasingly sure.

- - - - - - - - -
Other posts are there and there will porobably will be more tomorrow.

AT LAST, I sigh!!

Blimey - should I buy back in?

nice photos of product range showing on the other side---I'm beginning to get my hopes up again!

Well I should be wary.....looks like it's about to dive below .50p again !.

Down .01 as I spoke....going down to .40p possibly !.

Oblo - why not?

If for no other reason than we miss your posts!

'Afternoon all

I was one of the eight that visited the Stanelco offices yesterday and concur with what Tonyrelaxes has posted.

They seem to have got its act together, have sorted out their priorities, have a definite goal and have a clear stategy as to how to achieve their goal.

The bioplastic market is growing at a compound rate of 25% pa and I feel confident that Stanelco with grow by more than that figure year on year at least for the next three or so years. I feel that they will be cash positive sometime next year.

A good proportion of their sales are being generated by customer referrals, and enquiries and also repeat business.

Paul Mines said yesterday that the company will have coverage during Quarter 4 from brokers. He would not be allowing or encouraging that unless he was sure that there is a positive message to impart to the market..

I feel confident that the company has turned the corner in a screeching hand brake turn and is accelerating away to better things with Jeremy Clarkson shouting encouragment from the sidelines.

The oily one

An interesting number from yesterday, and on the Highlights page of the Presentation (slides on SEO website) - "direct sales yielded a 77% success rate of converting trials to production quantity orders in BioPlastics".

- - - - -
On a lighter note, the 'lowest common denominator' to this 77:23 ratio means at least 10 orders from 13 trials to this whole number %age, rounded up or down.

Oh, if only the previous management(s) had converted just one trial to an order. Remember WallMart, CocaCola, McDonalds to quote but 3. Yes, and lets not forget SealedAir (oops I've said too much).

- - - - -
Oily, the "screeching hand brake turn and is accelerating away" you heard was Sir Mark's Lamborghini - you must have had your eyes closed at my own driving! (I'm not used to cars. Life is a motorcycle).

did he buy the lambo by trading his millions of seo shares do you think???

No .....lol

I heard he had to sell it .....margin call :)


Only joking

Oily,

have you bought back in? I thought you were completely out some time ago.

Oblo
He's back not in (yet!)

He just likes revisiting the scene of the crime - a well known behaviour pattern.

oblomov

I am sitting and watching.

As per my post above. the new management have a firm handle on things and have turned the company around.

I expect it, based on the meeting in Southampton on Monday, to be cashflow positive by the first half of 2009 if not before.

If the 'coverage' which Paul Mines has promised in Q4 is really positive, then I shall be taking a new position in SEO.

The oily one

Tonyrelaxes/Oilywag,

Thanks for the update, info and opinions on your visit.
The impression I got reading between the lines of the last results were as such, but obviously an eye to eye so to speak must be worth more.

Appreciated, Greek.

Thanks Greek.
I dont know if you follow other freds but I posted this elsewhere yesterday -
- - - - - - - -
After a day of mulling over Mondays visit and comparing notes with some other attendees about 'off meeting' informal conversations and comments, I remain very happy to stay in.

Statements towards this include-
-the 77% convertion of trials into production orders.
-400% increase in BioPlastic direct sales.
-the BioPlast market is forecast to expand at least at 25% compound pa for the next 5 years and the statement "we expect to be ahead of that"

Other of my considerations include-
-although no full year forecasts have been made/announced they will be in an analysts note to be published in Q4. That shows management caution in not risking incorrect forecasts and leaving little time for falling short - and a confidence to tell us this now. (See also final bullet point of Outlook part of the presentation slides)
-an inkling in my mind(from informal seemingly unrelated comments made separately by 2 different of the SEO people present, to me and another attendees) that the preceeding bullet point might also be quite near. Something that will require shareholder approval (EGM?) might well be in the offing - not imminently though or they would have clamped up! Or maybe I am confusing gold with iron pyrites.

Thanks again.

3. BASIS OF CONSOLIDATION
The Group interim statements consolidate the results of the company and all of its subsidiary undertakings drawn up to 30 June 2008.
Subsidiaries are entities over which the Group has the power to control the financial and operating policies so as to obtain benefits from its activities. The Group obtains and exercises control through voting rights. At 30 June 2008 the subsidiary undertakings were Stanelco RF Technologies Limited, Stanelco Products Limited, InGel Technologies Limited, Zircotec Limited, Adept Polymers Limited, Aquasol Limited, Stanelco Inc, Biotec Holding GmbH Group, Biotec Biologische Naturverpackungen GmbH & Co KG and Biotec Biologische Naturverpackungen Forschungs-und Entwicklungs GmbH. During the 6 month period to 30 June 2008 the subsidiary undertakings InGel Industrial Limited, Starpol Packaging Systems Limited, Greenseal Technologies Inc and Starpol Edible Films Limited which were all dormant since incorporation were closed.

The Group's shareholding in Biotec is 50 per cent. However the Group is party to an agreement giving it a casting vote over all material
decisions and so Biotec is accounted for as a subsidiary on the basis of control.

Can anyone clarify to what extent Biotec's contribution is incorporated into SEO's accounts:
1) 50% of Biotec's profit/loss as previously proposed here

or

2) Biotec's full account as I believe the above to indicate